Treatment of Moderate to Severe Facial Acne Vulgaris
Public ClinicalTrials.gov record NCT00612573. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Study Randomized, Double-blind Study to Evaluate the Safety and Efficacy of 3 Doses of Doxycycline as Compared to Placebo in the Treatment of Moderate to Severe Facial Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Randomized, multi-center, double-blind, placebo-controlled 12-week study to assess the safety and efficacy of 3 doses of an oral formulation of Doxycycline oral tablets using the Investigator's Global Assessment (IGA) score and the absolute change from baseline in inflammatory lesion count in patients with moderate to severe facial acne vulgaris. Additionally, the absolute change from baseline in non-inflammatory and total lesions of the active study medication to placebo will be evaluated.
Study identification
- NCT ID
- NCT00612573
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 257 participants
Conditions and interventions
Conditions
Interventions
- Doxycycline 0.6 mg/kg/day Drug
- Doxycycline 1.2 mg/kg/day Drug
- Doxycycline 2.4 mg/kg/day Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Nov 2008 (Actual)
- Completion
- Dec 2008 (Actual)
- Last update posted
- Apr 22, 2013
2008
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Warner Chilcott Investigational Site | Encino | California | 91436 | — |
| Warner Chilcott Investigational Site | Fremont | California | 94538 | — |
| Warner Chilcott Investigational Site | Los Angeles | California | 90045 | — |
| Warner Chilcott Investigational Site | Sacramento | California | 95816 | — |
| Warner Chilcott Investigational Site | Denver | Colorado | 80210 | — |
| Warner Chilcott Investigational Site | Miami | Florida | 33175 | — |
| Warner Chilcott Investigational Site | Newnan | Georgia | 30263 | — |
| Warner Chilcott Investigational Site | Snellville | Georgia | 30078 | — |
| Warner Chilcott Investigational Site | Louisville | Kentucky | 40217 | — |
| Warner Chilcott Investigational Site | Clinton Township | Michigan | 48038 | — |
| Warner Chilcott Investigational Site | Albuquerque | New Mexico | 87106-5239 | — |
| Warner Chilcott Investigational Site | Rochester | New York | 14623 | — |
| Warner Chilcott Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Warner Chilcott Investigational Site | Cincinnati | Ohio | 45219 | — |
| Warner Chilcott Investigational Site | Portland | Oregon | 97210 | — |
| Warner Chilcott Investigational Site | Broomall | Pennsylvania | 19008 | — |
| Warner Chilcott Investigational Site | Fort Washington | Pennsylvania | 19034 | — |
| Warner Chilcott Investigational Site | Austin | Texas | 78759 | — |
| Warner Chilcott Investigational Site | College Station | Texas | 77845 | — |
| Warner Chilcott Investigational Site | Dallas | Texas | 75246 | — |
| Warner Chilcott Investigational Site | Houston | Texas | 77056 | — |
| Warner Chilcott Investigational Site | San Antonio | Texas | 78229 | — |
| Warner Chilcott Investigational Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00612573, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2013 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00612573 live on ClinicalTrials.gov.